Meta-hydroxyephedrine

also known as MHED

Investigated by: Biosense Webster, Inc. · Khaled Awad, MD · Washington University School of Medicine

today NCT02962076 · Ph 0

202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 0	NCT02962076	Sep 2020 → Mar 2023	ventricular tachycardia	Khaled Awad, MD	Terminated	No outcome recorded Stop: Enrollment

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Meta-hydroxyephedrine	ClinicalTrials.gov intervention name — accepted as the source's own label NCT02962076 ↗
Known as	MHED	“[C-11] Meta-hydroxyephedrine radioactive tracer (MHED)” NCT02962076 ↗